文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

活检遗传学分析诊断病因不明肾脏病

Diagnosis of Kidney Diseases of Unknown Etiology Through Biopsy-Genetic Analysis.
PubMed 文献 · Kidney Int Rep · 2023-07-22

本研究对52例活检证实的病因不明肾脏病患者在常规诊疗中行外显子测序(ES),采用定制肾脏基因panel分析,检出12种单基因肾病共21例(40.4%),最常见为胶原病(38.1%)和纤毛病(23.8%);女性及有肾脏病家族史者诊断率更高。

要点

  • 活检证实的病因不明肾脏病患者中ES诊断率为40.4%。
  • 最常见诊断为胶原病(38.1%)和纤毛病(23.8%)。
  • 女性及有肾脏病家族史者ES诊断率更高(57.1%和71%)。

核心结论

  • 对活检证实的病因不明肾脏病患者应检测ES,尤其是有肾脏病家族史的CKD患者可考虑作为一线工具。
  • ES与肾活检联合可能对肾脏疾病分类学产生重大影响。

研究设计与样本

  • 2020年1月至2021年12月常规诊疗中,对52例活检证实的病因不明肾脏病患者行ES,采用定制肾脏基因panel分析,依据美国医学遗传学与基因组学学会指南检测致病变异,并重新评估组织学发现。

主要发现

  • 21例(40.4%)检出12种单基因肾脏病。
  • 最常见诊断为胶原病(8/21,38.1%),其中COL4A3和COL4A4占这些诊断的80%;纤毛病(5/21,23.8%)。
  • 女性患者和有肾脏病家族史的患者ES诊断率更高(分别为57.1%和71%)。
  • 临床肾病类别与最终遗传诊断匹配率为72.7%,组织学肾脏病变与最终诊断匹配率为92.3%。
  • 肾小球和肾小管间质病例的遗传诊断与组织病理学发现完全一致;无肾小管炎的小管间质炎症仅见于肾小管病或纤毛病。

临床怎么用

  • 对活检证实的病因不明肾脏病患者,尤其是有肾脏病家族史的CKD患者,应考虑ES作为一线工具。
  • ES与肾活检联合可能对肾脏疾病分类学产生重大影响。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Previous studies have suggested that genetic kidney diseases in adults are often overlooked, representing up to 10% of all cases of chronic kidney disease (CKD). We present data obtained from exome sequencing (ES) analysis of patients with biopsy-proven undetermined kidney disease (UKD). METHODS: ES was proposed during routine clinical care in patients with UKD from January 2020 to December 2021. We used in silico custom kidney genes panel analysis to detect pathological variations using American College of Medical Genetics guidelines in 52 patients with biopsy-proven UKD with histological finding reassessment. RESULTS: We detected 12 monogenic renal disorders in 21 (40.4%) patients. The most common diagnoses were collagenopathies (8/21,38.1%), COL4A3 and COL4A4 accounting for 80% of these diagnoses, and ciliopathies (5/21, 23.8%). The diagnostic yield of ES was higher in female patients and patients with a family history of kidney disease (57.1% and 71%, respectively). Clinical nephropathy categories matched with the final genetic diagnoses in 72.7% of cases, whereas histological renal lesions matched with the final diagnoses in 92.3% of cases. The genetics diagnoses and histopathological findings were in complete agreement for both glomerular and tubulointerstitial cases. Interstitial inflammation without tubulitis was only observed in tubulopathies or ciliopathies. Isolated CKD, CKD with proteinuria or hematuria, and isolated proteinuria or hematuria yielded the highest diagnostic yields (54.6%, 52.6%, and 42.9%, respectively). CONCLUSION: ES done in patients with biopsy-proven UKD should be considered as a first-line tool for CKD patients with a family history of kidney disease. Combination of ES and kidney biopsy may have major impacts on kidney disease ontology.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Robert T, Greillier S, Torrents J, et al. Diagnosis of Kidney Diseases of Unknown Etiology Through Biopsy-Genetic Analysis. Kidney Int Rep. 2023. PMID: 37850010. doi:10.1016/j.ekir.2023.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。